Sharing the latest innovations in pediatric medicine and clinical practice from the experts at Monroe Carell Jr. Children’s Hospital at Vanderbilt.
New data suggests which suspicious elbow-fracture cases should be investigated.
Study reveals relationship between parents’ reluctance to get flu, COVID vaccines for their children.
Effective new therapies are on the market, but stigmas associated with yesterday’s drugs persist.
Black and Hispanic patients present with larger tumors, more distant disease than white patients.
Physicians are working to evaluate efficacy and seek FDA approval of new medication.
Experts in pediatric thyroid cancer discuss the most significant advances on the horizon.
Process must be customized to meet needs of individuals who have trouble naming and sharing emotions.
Early identification and management of visual disorders may mitigate negative effects, according to Vanderbilt co-author.
1 / 5
Study provides new input for predicting anterior temporal lobectomy outcomes.
Percutaneous Impella implantation introduced for eligible pediatric patients in select centers.
A new study explores advances in neoadjuvant chemotherapy and minimally invasive surgery.